drugset / Trial / NCT03570294
Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth
NaSingle-groupOpen-labelTreatment
Summary
Oxidative stress is recognized as a important factor in the pathogenesis premature birth. Preterm birth is defined as delivery before 37 completed weeks of gestation and it is the leading cause of neonatal morbidity and mortality. The investigators conducted this analysis to investigate the safety of administration of Atosiban - a reversible, competitive antagonist of the oxytocin receptor in the treatment of preterm labor and its impact on the level of oxidative stress after 48 hours of tocolytic treatment.
Timeline
- Start
- 2014-02-01
- Primary completion
- 2018-06-10
- Completion
- 2018-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atosiban | Other / unclassified | 100 ug | Intravenous |
Indications
No indication recorded.